Literature DB >> 21892694

Azathioprine induced hepatitis in patients with inflammatory bowel disease.

Rajaventhan Srirajaskanthan, Dilshad Valliani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21892694     DOI： 10.1007/s11096-011-9557-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


× No keyword cloud information.
  4 in total

1.  Azathioprine-induced severe cholestatic hepatitis in patient carrying TPMT*3C polymorphism.

Authors:  Chaker Ben Salem; Lynda Ben Salah; Colandane Belajouza; Kamel Bouraoui
Journal:  Pharm World Sci       Date:  2010-10-23

2.  Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis.

Authors:  G Roda; A Caponi; A Belluzzi; E Roda
Journal:  Dig Liver Dis       Date:  2009-04-18       Impact factor: 4.088

3.  Severe cholestatic hepatitis caused by azathioprine.

Authors:  Christoph Eisenbach; Christoph Goeggelmann; Christa Flechtenmacher; Wolfgang Stremmel; Jens Encke
Journal:  Immunopharmacol Immunotoxicol       Date:  2005       Impact factor: 2.730

Review 4.  Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity.

Authors:  J Romagnuolo; D C Sadowski; E Lalor; L Jewell; A B Thomson
Journal:  Can J Gastroenterol       Date:  1998-10       Impact factor: 3.522
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.